NCT06432452View on ClinicalTrials.gov

Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

June 15, 2026

Study Completion Date

July 1, 2026

Conditions
Coronary Spasm
Interventions
DRUG

Endothelin Receptor Antagonist

Oral capsules twice daily

OTHER

Placebo control

Oral capsules twice daily

Trial Locations (4)

5623EJ

Catharina Ziekenhuis, Eindhoven

3079DZ

Maasstad Hospital, Rotterdam

6525GA

RadboudUMC, Nijmegen

3584CX

UMC Utrecht, Utrecht

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

Maasstad Hospital

OTHER

lead

Radboud University Medical Center

OTHER